Nasser, Ibrahim – Trademark Portfolio
Entity Type: 01
Nasser, Ibrahim holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include GRENADE GIRLS, LITTLE GRENADE, SERIOUS SCENTS, and AMOR LOVE AMOUR. The owner is based in Chula Vista, CA.
732 Madison Avenue, #B
Chula Vista, CA 91910
Showing of trademarks Trademarks
Trademark Classifications
Nasser, Ibrahim's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Nasser, Ibrahim have?
Nasser, Ibrahim has 9 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 abandoned.
What trademark classes does Nasser, Ibrahim file in?
Nasser, Ibrahim files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nasser, Ibrahim's most well-known trademarks?
Nasser, Ibrahim's registered trademark portfolio includes well-known marks such as GRENADE GIRLS, LITTLE GRENADE, SERIOUS SCENTS, and AMOR LOVE AMOUR. These are among 8 currently registered trademarks in the portfolio.
What is Nasser, Ibrahim's trademark registration success rate?
Nasser, Ibrahim has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.